Evidence map›Paper›PMID 41522109›Full record

ArticleJournal of thoracic disease2025

A prospective randomized open-label trial of sirolimus versus paclitaxel-coated balloons for the side branch of

Qiyue Gao, Chi Liu, Guidong Xu, Xiaoping Peng, Xiaomin Chen, Xiantao Song, Rui Jing, Haiqiang Sang, Hong Jiang, Zuyi Yuan and 3 more

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qiyue GaoThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0000-0003-2222-3603
Chi LiuThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0009-0004-0869-6900
Guidong XuSuzhou Municipal Hospital, Suzhou, China.
Xiaoping PengThe First Affiliated Hospital of Nanchang University, Nanchang, China.
Xiaomin ChenThe First Affiliated Hospital of Ningbo University, Ningbo, China.
Xiantao SongBeijing Anzhen Hospital Capital Medical University, Beijing, China.
Rui JingTeda International Cardiovascular Hospital, Tianjin, China.
Haiqiang SangThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Hong JiangRenmin Hospital of Wuhan University, Wuhan, China.
Zuyi YuanThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ranzun ZhaoAffiliated Hospital of Zunyi Medical University, Zunyi, China.
Changling LiThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0009-0003-3908-909X
Qiyuan XuThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0000-0003-0025-1777

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Drug-coated balloons (DCBs) are commonly used in small coronary arteries. A recent trial reported similar outcomes between paclitaxel-coated balloons (PCBs) and sirolimus-coated balloons (SCBs) in side branch (SB) stenosis after stenting main branch (MB). This trial investigated whether SCBs and PCBs produce similar effects in Methods: In this prospective, multicenter, randomized, non-inferiority clinical trial, patients with Results: During June 2021 and October 2023, a total of 241 patients (SCB 121 Conclusions: In patients with

Indexed as

coronary bifurcation lesionsSirolimus-coated balloon (SCB)target lesion stenosis (TLS)

Identifiers

PMID41522109
PMCPMC12780450

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.